<DOC>
	<DOC>NCT00610350</DOC>
	<brief_summary>The aim of this study is to investigate whether pharmacological pre-treatment with levosimendan reduces intensive care unit (ICU) length of stay in patients undergoing elective myocardial revascularization under cardiopulmonary bypass.</brief_summary>
	<brief_title>Levosimendan and Myocardial Protection</brief_title>
	<detailed_description />
	<mesh_term>Simendan</mesh_term>
	<criteria>age â‰¥18 years intention to perform firsttime multivessel CABG unstable angina valvular disease diabetes mellitus treated with sulphonylurea drugs renal failure severe hepatic disease severe chronic obstructive pulmonary disease a history of prior CABG surgery recent myocardial infarction (MI) within the previous month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Levosimendan</keyword>
	<keyword>pre-conditioning</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>myocardial function</keyword>
	<keyword>contractility</keyword>
	<keyword>heart</keyword>
	<keyword>ischaemia</keyword>
</DOC>